HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serological identification of URGCP as a potential biomarker for glioma.

AbstractAIM:
Glioblastoma multiforme (GBM) is one of the most frequent human brain tumor and causes dismal outcome. To identify tumor-associated antigens in GBM patients may find potential diagnostic markers and immunotherapeutic targets. In this study, we identified a gene termed URGCP using the serological identification of antigens by recombinant A2B5 positive glioma cDNA library. The gene product of URGCP is immunogenic in GBM after tested in allogenic patients serum screening.
METHODS AND RESULTS:
GBM patients with an auto-antibody response against URGCP show longer survival than those without URGCP response. In additional, we show that URGCP was high expression in most GBM tissues and cell lines compared with normal brain tissues and majorly co-expressed with stem cell marker A2B5.
CONCLUSION:
We identified a potential new biomarker of GBM, URGCP. The findings indicate that URGCP is immunogenic in human GBM and suggest its potential use as diagnostic and immunotherapeutic for GBM patients.
AuthorsLing-Chao Chen, Hai-Yan Zhang, Zhi-Yong Qin, Yang Wang, Ying Mao, Yu Yao, Liang-Fu Zhou
JournalCNS neuroscience & therapeutics (CNS Neurosci Ther) Vol. 20 Issue 4 Pg. 301-7 (Apr 2014) ISSN: 1755-5949 [Electronic] England
PMID24308561 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2013 John Wiley & Sons Ltd.
Chemical References
  • Antibodies, Neoplasm
  • Antigens, Neoplasm
  • Biomarkers, Tumor
  • Neoplasm Proteins
  • RNA, Messenger
  • URGCP protein, human
Topics
  • Adult
  • Aged
  • Antibodies, Neoplasm (blood)
  • Antigens, Neoplasm (blood, immunology, metabolism)
  • Biomarkers, Tumor (blood, immunology, metabolism)
  • Brain (metabolism)
  • Brain Neoplasms (immunology, metabolism)
  • Cell Line, Tumor
  • Female
  • Glioblastoma (immunology, metabolism)
  • Glioma (immunology)
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Proteins (immunology, metabolism)
  • Prognosis
  • RNA, Messenger (metabolism)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: